Skip to main content

Table 1 Baseline clinical characteristics of enrolled dilated cardiomyopathy cases

From: Genetic analysis using targeted next-generation sequencing of sporadic Chinese patients with idiopathic dilated cardiomyopathy

Characteristics (n = 24)
Age at onset, years 39.8 ± 12.3
Female gender, n (%) 5 (21%)
Hypertension, n (%) 6 (25%)
Diabetes mellitus, n (%) 2 (8%)
Smoking 6 (25%)
Alcohol 4 (17%)
Cholesterol, mmol/L 4.7 ± 1.6
LDL-c, mmol/L 3.2 ± 1.1
NT-proBNP, pg/mL 2057.5 (698,18,381)
NYHA III or IV, n(%) 21 (87.5%)
ICD, n (%) 2 (8%)
Atrial fibrillation 2 (8%)
Complete RBBB/LBBB 1 (4%)
LVEF, % 27.0 ± 9.9
LVEDD, mm 70.1 ± 7.8
LA diameter, mm 49.4 ± 9.6
ACEI/ARB/ARNI, n (%) 18 (75%)
Beta-blockers, n (%) 21 (87.5%)
Spironolactone, n (%) 22 (91.7%)
Diuretics, n (%) 21 (87.5%)
  1. All variables are given as either number present (% of total number) or mean ± SD, except for NT-proBNP (N-terminal B-type natriuretic peptide), which is given as mean and range
  2. NYHA, New York Heart Association functional classification; ICD, implantable cardioverter defibrillator; RBBB/LBBB, right bundle branch block/left bundle branch block; LVEDD, left ventricular end-diastolic dimension; LA, left atrium; ACEI/ARB/ARNI, angiotensin converting enzyme inhibitor/angiotensin receptor blocker/angiotensin receptor-neprilysin inhibitor